Prem Watsa - Fairfax Financial Holdings 13F Activity & Position Changes (Q4 2024)

As of Dec 31, 2024, the Fairfax Financial Holdings portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Feb 14, 2025. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2024, the filing reported:

New Buys - Cleveland-Cliffs Inc., CVS Health Corporation, Revance Therapeutics, Inc., Molson Coors Beverage Company

Increases - ATS Corporation, Bank Nova Scotia Halifax Pfd 3, Garrett Motion Inc., Helmerich & Payne, Inc., The Kraft Heinz Company, and 1 more

Reductions - Capri Holdings, Xeris Biopharma Holdings, Inc.

Complete Exits - Alphabet Inc., Intel Corporation, Restaurant Brands International, TEGNA Inc

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q4 2024	ATS ATS Corporation	ATS Corporation	Buy	+2,429,700	+4285.2%	$73.87M	2,486,400
Q4 2024	BNS Bank Nova Scotia Halifax Pfd 3	Bank Nova Scotia Halifax Pfd 3	Buy	+70,000	+24.2%	$19.27M	359,100
Q4 2024	CLF Cleveland-Cliffs Inc.	Cleveland-Cliffs Inc.	Buy - Position Entry	+5,899,273	-	$55.45M	5,899,273
Q4 2024	CPRI Capri Holdings	Capri Holdings	Sell	-124,000	-61.4%	$1.64M	78,100
Q4 2024	CVS CVS Health Corporation	CVS Health Corporation	Buy - Position Entry	+2,712,000	-	$121.74M	2,712,000
Q4 2024	GOOGL Alphabet Inc.	Alphabet Inc.	Sell - Position Exit	-274,620	-100.0%	$0.00	-
Q4 2024	GTX Garrett Motion Inc.	Garrett Motion Inc.	Buy	+18,600	+6.5%	$2.75M	304,360
Q4 2024	HP Helmerich & Payne, Inc.	Helmerich & Payne, Inc.	Buy	+219,000	+39.5%	$24.79M	774,105
Q4 2024	INTC Intel Corporation	Intel Corporation	Sell - Position Exit	-190,000	-100.0%	$0.00	-
Q4 2024	KHC The Kraft Heinz Company	The Kraft Heinz Company	Buy	+2,564,000	+341.9%	$101.77M	3,314,000
Q4 2024	PFE Pfizer, Inc.	Pfizer, Inc.	Buy	+190,000	+41.2%	$17.27M	650,900
Q4 2024	QSR Restaurant Brands International	Restaurant Brands International	Sell - Position Exit	-42,000	-100.0%	$0.00	-
Q4 2024	RVNC Revance Therapeutics, Inc.	Revance Therapeutics, Inc.	Buy - Position Entry	+21,158	-	$64.11K	21,158
Q4 2024	TAP Molson Coors Beverage Company	Molson Coors Beverage Company	Buy - Position Entry	+1,186,500	-	$68.01M	1,186,500
Q4 2024	TGNA TEGNA Inc	TEGNA Inc	Sell - Position Exit	-32,000	-100.0%	$0.00	-
Q4 2024	XERS Xeris Biopharma Holdings, Inc.	Xeris Biopharma Holdings, Inc.	Sell	-31,250	-18.3%	$472.14K	139,687